Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Cerilliant
Citi
Federal Trade Commission
Chinese Patent Office
Mallinckrodt
Farmers Insurance
UBS
Covington

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071766

« Back to Dashboard
NDA 071766 describes DESIPRAMINE HYDROCHLORIDE, which is a drug marketed by Sandoz, Actavis Totowa, Ani Pharms Inc, Amneal Pharms Co, Heritage Pharms Inc, Impax Labs Inc, and Usl Pharma, and is included in nineteen NDAs. It is available from thirteen suppliers. Additional details are available on the DESIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

Summary for NDA: 071766

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 071766

Suppliers and Packaging for NDA: 071766

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride
TABLET;ORAL 071766 ANDA Actavis Pharma, Inc. 45963-345 45963-345-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-345-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Oct 5, 1987TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Moodys
US Army
Harvard Business School
QuintilesIMS
Argus Health
Queensland Health
Cerilliant
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot